Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study
October 01, 2024 08:00 ET
|
Halberd Corp.
Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study
Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology
October 01, 2024 07:00 ET
|
Lifecore Biomedical, Inc.
Multi-Million Dollar Development Agreement Establishes Lifecore as Lindy Biosciences’ Preferred CDMO Offers Lifecore Key Access Point into Manufacture and Fill/Finish of Next-Generation...
Biopharmaceutical Market Size Projected to Reach USD 17,902.42 Billion by 2032 with 49.60% CAGR – SNS Insider
September 27, 2024 09:24 ET
|
SNS Insider pvt ltd
Pune, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Biopharmaceutical Market Size & Growth Analysis: According to SNS Insider, The Biopharmaceutical Market Size was valued at USD 572.33 Billion in 2023...
Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events
September 25, 2024 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
ADR Ratio Change
September 19, 2024 16:30 ET
|
Biodexa Pharmaceuticals PLC
September 19, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical...
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational
September 19, 2024 07:00 ET
|
Lifecore Biomedical, Inc.
Installation and Qualification Successfully Completed for Closed-System Filler for Pre-Filled Syringes, Vials, and Cartridges Offers State-of-the-Art Speed and Aseptic Isolation Required for...
Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD
September 11, 2024 08:00 ET
|
Halberd Corp.
Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD
Halberd Corp. Issues Letter to Shareholders - Patented LDN+ Evolves into WatchDawg™ for Veteran Suicide Reduction
September 09, 2024 09:31 ET
|
Halberd Corp.
Halberd Corp. Issues Letter to Shareholders - Patented LDN+ Evolves into WatchDawg™ for Veteran Suicide Reduction
Halberd Corp. Issues Letter to Shareholders - Patented LDN+ Evolves into WatchDawg™ for Veteran Suicide Reduction
September 04, 2024 08:00 ET
|
Halberd Corp.
Halberd Corp. Issues Letter to Shareholders - Patented LDN+ Evolves into WatchDawg™ for Veteran Suicide Reduction
Healthy Longevity is One of Key Development Goals of ANEW’s Novel Gene Therapy
September 04, 2024 07:46 ET
|
ANEW MEDICAL, INC.
Healthy Longevity is One of Key Development Goals of ANEW’s Novel Gene Therapy